Explore
placeholder image

Multimedia

  • February 13, 2024

    BioAge Labs Raises $170m to Develop Therapies Using AI

  • January 4, 2023

    Virtual KOL event: Positive Ph1b topline muscle atrophy data for BGE-105 & design of Phase 2 trial

  • November 17, 2022

    Investing in the Age of Longevity

  • November 14, 2022

    BioAge's unique approach to targeting aging

Left gradient Right gradient